Discovery, development, and characterization of SPY002 and SPY072, two novel extended half-life monoclonal antibodies targeting TL1A: in vitro properties, in vivo pharmacology, pharmacokinetics, and preclinical safety.
来源：PubMed发布日期：2026-12-01作者：Siegel M, Zhu E, Rios D, Kang BH, McNally J0 次点击